October 30, 2025
Critical Choices
As we anticipated Dexcom acknowledged the issues with the G7 when they released earnings this afternoon. While the actual numbers were just fine it’s what happens going forward that matters more. Based on after hours trading the street is once again focusing on the short-term negatives and failing to consider the long-term possibilities. As we have noted previously 2025 will go down as a transitional year for Dexcom. The key going forward will be the choices the company makes.
While we still believe that it would be a mistake to introduce a sensor which measures ketones as . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
